PRODUCTS
ZytoLight ® SPEC ERG/TMPRSS2 TriCheckTM Probe
The ZytoLight ® SPEC ERG/TMPRSS2 TriCheckTM Probe is designed to detect deletions between the ERG and the TMPRSS2 gene at 21q22 resulting in the TMPRSS2-ERG fusion frequently observed in prostate cancer. Furthermore, the triple color approach allows the detection of other translocations affecting either of these genes.
Probe Maps
Ordering Information
| Prod. No.: | Tests¹ (Volume): | Intended Use²: | ||
|---|---|---|---|---|
| Z-2135-200 |
|
 |
Download Information
| 1 | Using 10 μl probe solution per test. |
| 2 | In vitro diagnostic medical device according to EU directive 98/79/EC. CE IVD only available in certain countries. All other countries research use only! Please contact your local dealer for more information. |
